Effect of Gly-His-Lys peptide and its analogs on pain sensitivity in mice
Frontiers in Cellular and Infection Microbiology, 12, 915701
[5] In essence, it releases the brake on the pituitary, causing a surge in the patients own GH output
Further there are several other companies pursuing therapies for chronic spontaneous urticaria addressing other receptors of interest, such a Genentech, Inc., Sanofi, Celldex Therapeutics, Inc., Jasper Therapeutics, Inc., Novartis AG, Third Harmonic Bio, Inc., and Blueprint Medicines (a Sanofi company)
As treatment options multiply, individualized care strategies will become even more important
Oral antihistamines (diphenhydramine or cetirizine) do not treat the underlying inflammatory reaction but provide itch relief, particularly at night